Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2019 May 30;177(1):207–214. doi: 10.1007/s10549-019-05293-x

Employment trends in young women following a breast cancer diagnosis

Shoshana M Rosenberg 1,2, Ines Vaz-Luis 3, Jingyi Gong 2, Padma Sheila Rajagopal 4, Kathryn J Ruddy 5, Rulla M Tamimi 2,6, Lidia Schapira 7, Steven Come 2,8, Virginia Borges 9, Janet S de Moor 10, Ann H Partridge 1,2
PMCID: PMC7265819  NIHMSID: NIHMS1589651  PMID: 31147983

Abstract

Purpose

Little is known about how a breast cancer diagnosis and treatment affects job-related outcomes in young women with breast cancer, who are an integral part of the workforce. We sought to describe employment trends among young breast cancer survivors.

Methods:

911 women with non-metastatic breast cancer were surveyed about employment-related outcomes 1-year post-diagnosis. Participants were enrolled in the Young Women’s Breast Cancer Study an ongoing, multi-center cohort of women diagnosed with breast cancer at age ≤40.

Results:

Among 911 women, median age at diagnosis was 37 years (range: 17–40). Most women (80%, n=729) were employed 1-year post-diagnosis. Among the 7% (n=62) employed before diagnosis but who reported unemployment at 1-year, approximately half reported they were unemployed for health reasons. Among employed women, 7% said treatment affected their ability to perform their job. Women with stage 3 disease (vs. stage 1 disease, odds ratio (OR): 3.73, 95% CI, 1.39–9.97) and those who reported having money to pay bills after cutting back or difficulty paying bills at baseline (vs. having enough money for special things, OR: 2.70, 95% CI, 1.32–5.52) at baseline were more likely to have transitioned out of the workforce.

Conclusions:

Our results suggest an impact of disease burden and socioeconomic status on employment in young breast cancer survivors. There is a need to ensure young survivors who leave the workforce following diagnosis are sufficiently supported given the potential adverse psychosocial and financial impacts unemployment on survivors, their families, communities, and society.

Keywords: employment, breast cancer, survivorship, outcomes

INTRODUCTION

The number of people surviving cancer is expected to rise to approximately 18 million by 2022 [1]. Female breast cancer represents approximately 15% of all new cancer cases in the United States (US), with an estimated 90% of breast cancer patients alive at 5 years after diagnosis [2]. Therefore, there is a need to focus on breast cancer survivorship issues to gain a better understanding of how a breast cancer diagnosis can impact long-term medical, emotional, and social outcomes [3].

Recent data suggest a substantial proportion (40%–76%) of working-age females are employed when diagnosed with breast cancer, making it relevant and important to understand employment trends in breast cancer survivors [37]. Some prior studies suggested that most breast cancer survivors are able to maintain employment (although some may take time off during treatment), while others indicate that a substantial proportion of patients do not return to work after cancer [5, 7, 8]. The prevalence of unemployment following breast cancer surgery ranged from 5.6%–56.3% in a recently published systematic review and meta-analysis [9]. In one study, women who underwent surgery for breast cancer were three times more likely than healthy women to leave work within the first year of treatment [10] supporting other studies that have also found the risk of unemployment to be higher among survivors when compared to individuals without cancer [11]. In addition, breast cancer can impact survivors’ ability to work and job performance (e.g. cancer-changed physical and cognitive functional ability can negatively impact work productivity) and lead to them experiencing higher work-related distress [4, 1215].

Almost 10% of new breast cancer cases each year in the US occur in women younger than 40 [16, 17]. Breast cancer among younger patients usually requires more aggressive treatment that can lead to more physical and psychosocial suffering [16, 18]. Further, financial sequelae may be even more pronounced for young adults with cancer given their life stage, potentially increasing the burden for this vulnerable group [19]. Given that young women are an integral part of the workforce, a breast cancer diagnosis can have a profound impact on career and employment opportunities that may result in long-term social and economic consequences [12].

Young adult cancer survivors are poorly represented in most of the existent series addressing the socioeconomic burden of cancer with little known about the impact of a breast cancer diagnosis and treatment on a young woman’s desire and ability to work. Using a contemporary cohort of young breast cancer patients, we sought to characterize employment patterns in the year following diagnosis, as well as to describe the work experience among those who remained employed and potential barriers to rejoining the workplace.

METHODS

Participants

Helping Ourselves, Helping Others: The Young Women’s Breast Cancer Study (YWS) is a multi-institutional prospective cohort study that enrolled women diagnosed with breast cancer at age 40 and younger between 2006 and 2016. Academic and community hospitals in Massachusetts and academic sites in Denver, Colorado and Rochester, Minnesota contributed data to this analysis. Women enrolled at a participating site in Canada were excluded because their baseline and follow-up surveys were modified and did not include employment items. Informed consent was obtained from all individual participants included in the study. After informed consent, women complete a baseline survey (median: 4.6 months after diagnosis) and then are surveyed twice a year for the first three years following diagnosis and annually thereafter. Women who responded to both the baseline and one-year following diagnosis surveys were eligible for inclusion in the current analysis. The YWS is approved by the Institutional Review Board at the Dana-Farber/Harvard Cancer Center as well as at other study sites.

Measures

Employment trajectory

At baseline, a question adapted from the National Statistics Classification – Standard Occupational Classification asked participants to best describe their work life in the three months before they were diagnosed [20]. Options included employed full-time, employed part-time, self-employed, unemployed for health reasons, unemployed for other reasons, and full-time homemaker. At one year, participants were asked about their work life “right now”, with the same response options. Women who reported any type of employment (full-time, part-time, or self-employed) were categorized as “employed” while those who reported unemployment or being a home-maker were categorized as “unemployed.” Employment trajectory was categorized as follows: 1) women who reported employment both pre-diagnosis and at one year after; 2) women not in the workforce at both time points; 3) women unemployed pre-diagnosis but employed at one year; 4) women who reported pre-diagnosis employment but were no longer in the workforce when surveyed one year after diagnosis.

Employment after cancer

Job satisfaction was assessed with a single question on the one-year survey with four response options including completely dissatisfied, somewhat dissatisfied, somewhat satisfied, completely satisfied. Additional items that assessed job outcomes at one year included the degree to which cancer or cancer treatment limited one’s ability to perform job responsibilities (not at all, a little bit, quite a bit, very much), whether an employer made accommodations so it was easier to do one’s job (yes; no-but accommodations were needed; no, I did not need any special accommodations), and how likely it was that the respondent would be working at all in one year (very unlikely, somewhat unlikely, somewhat likely, very likely)[21]. Transition out of the workforce was defined as women who reported pre-diagnosis employment but were no longer in the workforce when surveyed one year after diagnosis.

Study population characteristics

Socio-demographic characteristics, including education, marital status, and parity, as well as insurance status, were assessed on the baseline and/or one-year survey. Race and ethnicity were also self-reported at baseline. If missing or unknown, we obtained this information from the medical record. Perceived financial comfort at baseline was measured with a single question asking participants to describe their current financial situation, with the following response options: after paying the bills, still have enough money for the special things that you want; you have enough money to pay the bills, but little spare money to buy extra or special things; you have enough money to pay the bills, but only because you have cut back on things; you are having difficulty paying the bills no matter what you do [22].

Medical records were reviewed to ascertain disease stage and receptor status. Treatment information, including chemotherapy, radiation, and surgery were evaluated using patient self-report on study surveys in combination with medical record review.

Statistical Analysis

We described the overall cohort and employment trajectories with frequencies and means calculated for categorical and continuous covariates, respectively. We used t-tests and calculated chi-square statistics to examine socio-demographic differences in employed and unemployed women prior to diagnosis, and differences in job-related outcomes by baseline perceived financial comfort among women employed at one-year after diagnosis. Finally, we used univariable and multivariable logistic regression (excluding women who reported being out of the workforce at both timepoints) to identify factors associated with transitioning out of the work-force at one-year following diagnosis; p-values ≤0.05 were considered statistically significant. Analyses were conducted using SAS v9.4 (Cary, N.C.).

RESULTS

Cohort characteristics

Among 2162 women deemed eligible following pathologic record review, 1302 provided written informed consent and were enrolled in the YWS (response rate: 60%). The analytic cohort included 911 women with Stage 0–3 breast cancer who had reported their employment status data on both the baseline and one-year survey (Figure). Patient, disease, and treatment characteristics are detailed in Table 1. Median age at diagnosis was 37 years (range: 17–40), 78% of women were married or living as married, almost two-thirds had a child prior to diagnosis, and 85% had at least a college degree. Most (85%) identified as white and non-Hispanic. Regarding perceived financial comfort, 53% reported that after paying the bills, they still had enough money for special things; 29% said they had enough money to pay the bills, but little spare money to buy extra or special things; and 19% said they had enough money to pay the bills, but only because they cut back on things or they had difficulty paying the bills. Most women presented with either Stage 1 or Stage 2 (77%) disease; the vast majority received chemotherapy (75%) and had a mastectomy (70%).

Figure.

Figure.

Study flow chart of participants included in the analytic sample

YWS: Young Women’s Breast Cancer Study

*includes 62 patients enrolled at site in Toronto, Canada

Table 1.

Study population characteristics

N=911
Median age at diagnosis (range) 36 (17–40)
No. (%)
Race/ethnicity
 white non-Hispanic 787 (85)
 Other race/ethnicity 124 (14)
Insured
 Yes 903 (99.9)
 No 1 (0.01)
 Missing/unknown 7
Education
 College degree or greater 771 (85)
 No college degree 137 (15)
 Missing/unknown 3
Financial comfort
 Enough money for special things 474 (53)
 Enough money to pay bills but little spare money for extras 258 (29)
 Money to pay bills but only after cutting back/difficulty paying bills 167(19)
 Missing/unknown 12
Marital status
 Married/Living as married 709 (78)
 Unmarried 200 (22)
 Missing/unknown 2
Parity
 At least one child before diagnosis 588 (65)
 No children 315 (35)
Missing/unknown 8
Stage
 0 78 (9)
 1 322 (35)
 2 384 (42)
 3 127 (14)
Chemotherapy
 Yes 685 (75)
 No 226 (25)
Radiation
 Yes 570 (63)
 No 341 (37)
Surgery
 Mastectomy 639 (70)
 Lumpectomy 272 (30)

Employment prior to diagnosis

Most women were employed either full time (n=578, 63%), part-time (n=148, 16%) or identified as self-employed (n=36, 4%) in the three months prior to their breast cancer diagnosis while 3% (n=30) were unemployed for health or for other reasons and 13% (n=119) were full-time homemakers. Among those not in the workforce, 90% had at least one child (vs. 60% of employed women, p<0.0001) and 91% were married/living as married (vs. 76% of employed women, p<0.0001). Those employed prior to their diagnosis were also younger at diagnosis (mean age: 35.9 years vs. 37.0 years, p=0.0004).

Employment outcomes at one-year post-diagnosis

Most women (n=700, 77%) were employed both before diagnosis and at one year after diagnosis. Three percent (n=29) of women were unemployed prior to diagnosis but reported employment at one year. Thirteen percent (n=120) were unemployed both before diagnosis and at one year while 7% (n=62) were employed prior to diagnosis but reported unemployment at one year. Among those who transitioned out of the workforce (n=62), approximately half (52%, n=32) reported they were unemployed for health reasons.

Factors associated with transition out of the workforce are included in Table 2. In univariable analyses, women with stage 3 disease (vs. stage 1, odds ratio [OR]: 5.57, 95% confidence interval [CI], 2.63–11.81), those who reported having money to pay bills after cutting back or difficulty paying bills at baseline (vs. having enough money for special things, OR: 3.41, 95% CI, 1.79–6.51), those treated with chemotherapy (vs. no chemotherapy, OR: 3.81, 95% CI, 1.50–9.65), those who had a mastectomy (vs. lumpectomy, OR: 2.13, 95% CI, 1.09–4.16), and those without a college degree (vs. college educated, OR: 2.39, 95% CI, 1.30–4.41) were more likely to have transitioned out of the workforce. In multivariable analyses, having stage 3 (vs. stage 1 disease, OR: 3.73, 95% CI, 1.39–9.97) and those who reported having money to pay bills after cutting back or difficulty paying bills at baseline (vs. having enough money for special things, OR: 2.70, 95% CI, 1.32–5.52) remained significantly associated with transitioning out of the workforce. Marital status, parity, race/ethnicity, receipt of radiation, and age at diagnosis were not significantly associated with workforce transition in either univariable or multivariable analyses.

Table 2.

Univariable and multivariable analysis of factors associated with transition out of the workforce 1 year post-diagnosis (n=772)a

Univariable Multi-variable
OR (95% Cl) OR (95% Cl)
Age at diagnosis (years) 0.99 (0.92–1.05) 0.99 (0.91–1.06)
Race/ethnicity
 White non-Hispanic 1.24 (0.55–2.80) 1.41 (0.59–3.38)
 Other race/ethnicity reference reference
Education
 No college degree 2.39 (1.30–4.41) 1.77 (0.90–3.46)
 College degree or greater reference reference
Financial comfort
 Enough money for special things reference reference
 Enough money to pay bills but little spare money for extras 1.72 (0.90–3.30) 1.49 (0.75–2.94)
 Money to pay bills but only after cutting back/difficulty paying bills 3.41 (1.79–6.51) 2.70 (1.32–5.52)
Marital status
 Married/Living as married 1.06 (0.57–1.97) 0.99 (0.48–2.05)
 Unmarried reference reference
Parity
 At least one child before diagnosis 1.70 (0.95–3.04) 1.56 (0.78–3.12)
 No children reference reference
Stage
 0 1.11 (0.30–4.04) 2.69 (0.45–16.10)
 1 reference reference
 2 1.68 (0.83–3.43) 1.26 (0.56–2.83)
 3 5.57 (2.63–11.81) 3.73 (1.39–9.97)
Chemotherapy
 Yes 3.81 (1.50–9.65) 3.34 (0.79–14.23)
 No reference Reference
Radiation
 Yes 1.55 (0.86–2.76) 1.09 (0.50–2.38)
 No reference reference
Surgery
 Mastectomy 2.13 (1.09–4.16) 1.42 (0.63–3.22)
 Lumpectomy reference reference
a

Excludes women (n=120) who reported being out of the workforce both before diagnosis and one year after diagnosis and women who were missing data for variables included in the univariable and multi-variable models (n=19).

OR: Odds ratio; CI: Confidence Interval

Among women employed one year after diagnosis (Table 3), 73% (n=529) were somewhat or completely satisfied with their job while 27% (n=192) were dissatisfied. Only 7% (n=51) said cancer or treatment limited their ability to perform their job quite a bit or very much. Ninety-six percent (n=688) said they were somewhat or very likely to be working one year from now. Two-thirds (n=464) of women reported a willingness by their employer to make accommodations following a breast cancer diagnosis. While 34% (n=240) of patients said that their employer did not make any accommodations to make their jobs easier, for the majority (n=211, 88%) special accommodations were not reported as necessary. Women who reported financial stress at baseline were more likely to report dissatisfaction with their job (p=0.008) and less likely to report that their job was willing to make needed accommodations for them following their diagnosis (p=0.0005).

Table 3.

Perceived financial comfort at baseline and employment outcome and perceptions among those employed at 1 year post-diagnosis

Total, No. (%) (n=723)a After paying, still have enough money for special things, No (%) (n=387) Enough money to pay bills but little spare money for extras, No. (%) (n=213) Money to pay bills but only after cutting back/difficulty paying bills, No. (%) (n=123) p-value
How satisfied are you with your job? 0.008
 Somewhat/completely satisfied 529 (73) 299 (78) 151 (71) 79 (64)
 Somewhat/completely dissatisfied 192 (27) 86 (22) 62 (29) 44 (36)
 Missing (N) 2 2 --- ---
How much does your cancer or cancer treatment limit your ability to perform your job responsibilities? 0.62
 Not at all/A little bit 669 (93) 357 (93) 200 (94) 112 (91)
 Quite a bit/Very much 51(7) 27 (7) 13 (6) 11 (9)
 Missing (N) 3 3 --- ---
After your cancer diagnosis, did your employer make any accommodations so it was easier for you to do your job? <0.001
 Yes 464 (66) 256 (67) 142 (68) 66 (57)
 No, but accommodations were needed 29 (4) 8 (2) 8 (4) 13 (11)
 No, but I did not need any special accommodations 211 (30) 116 (31) 59 (28) 36 (31)
 Missing (N) 19 7 4 8
How likely is it that you will be working at all one year from now? 0.34
 Very/somewhat likely 688(96) 368 (96) 205 (97) 115 (94)
 Very/somewhat unlikely 30 (4) 15 (4) 7 (3) 8 (7)
 Missing (N) 5 4 1 ---
a

Of 729 employed at 1 year, n=6 excluded due to missing perceived financial comfort information

DISCUSSION

It is a societal responsibility to understand the effect of cancer on employment and return to work after diagnosis [4]. This study represents one of the first to examine the question of employment exclusively among women diagnosed with breast cancer at age 40 and younger in the United States. In this large cohort of young women with breast cancer, the vast majority of patients were working one year after diagnosis. Nevertheless, a substantial minority (20%, approximately one-third of whom were previously employed) was unemployed at that time point. Of those who were previously employed, over half cited their health as the reason for not being employed at one-year. Although most patients employed after cancer did not report work difficulties, 27% were not satisfied with their work and this was associated with greater financial stress as reported at baseline. In addition to higher stage of disease, financial stress was also associated with transition out of the work force.

Prior research has revealed that women who continue working through treatment and recovery, or who resume work after treatment demonstrate lower levels of psychosocial distress, higher levels of physical and mental functioning, improved quality of life as well as higher self-esteem and social functioning [3, 23]. Heterogeneous studies, focused on different populations, time frames, and employment outcomes, have demonstrated variable employment trends among breast cancer survivors [1215]. Our study focused on a young population suggested that employment difficulties are not a major issue for a high proportion of patients who were employed at one year following their diagnosis; most were satisfied with their work.

However, employment after breast cancer still posed challenges for some women. Employment difficulties are likely complex and multifactorial, as supported by our data. Our study shows that financial stress can influence not only transition out of the workforce but also job satisfaction. This is consistent with data from prior studies suggesting that the most fragile patients are at higher risk of work difficulties after cancer, with financial factors having a profound influence on the employment status of breast cancer survivors: lower household income, part-time employment, and duration of unemployment before diagnosis have been associated with employment problems after diagnosis [8, 24, 25]. African American and Latina women additionally report greater job loss after cancer compared to white women at 18 months [2628], though we did not find an association between race/ethnicity and employment in our population. Although we did not directly examine the effect of employer support on return to work, our findings indicate that those who experience more financial stress are less satisfied at work and have less support/accommodation from their employers. This is consistent with prior data among cancer survivors that has shown a relationship between a worse employment experience and perceived weak social support in the workplace as well as employer discrimination/inflexibility [24, 29, 30]. Our finding that those with at least a college degree were less likely to have transitioned out of the workforce was not maintained in the multivariable model. Prior research has revealed conflicting data regarding the impact of education on employment in breast cancer survivors: some find an association with lower levels of education and reduced likelihood of return to work and others do not [8, 10, 24, 30].

Also consistent with prior studies in which women with more aggressive tumors and those undergoing chemotherapy have lower employment rates after breast cancer diagnosis [7, 31, 32]. In our analysis, patients with higher stage tumors were more likely than others to transition out of the workforce, though receipt of chemotherapy was not associated with lower employment on multivariable analysis. Importantly, standard chemotherapy would generally have been completed prior to the one-year follow-up survey, and while many women may have taken some time off during treatment, most would be back working as they were prior to diagnosis by one year.

It is possible that other factors that we did not investigate could negatively impact employment, such as having a co-morbid condition. Further, employed breast cancer survivors may experience work-related difficulties that were not explored here, including work productivity, ability, stress, and longer-term sustainability issues [12]. While among those who were employed at one year job satisfaction was high and most indicated that diagnosis or treatment did not negatively affected job performance, we were unable to explore whether those who did leave the workforce did so due to low job satisfaction or to the lack of accommodations made by their employer.

Findings from our study should be considered in the context of its limitations. Our cohort population is predominantly white and non-Hispanic, insured, is well-educated, and most young women do not report major financial difficulties. It is possible that the proportion of young survivors who would not rejoin the workforce or would be unsatisfied with work at one year would be larger in a more diverse population. In addition, findings from this analysis may not be generalizable to women in other countries, where work environments, expectations, and laws are different. Without a healthy control population, it is not possible to make comparisons with an age-matched non-cancer survivor cohort although all of these women were 40 and under at diagnosis. We also do not have sufficient information to assess to what degree return to work was financially or quality-of-life driven, or to assess the perceived impact of cancer on ability to work or productivity.

Our results represent good news for the majority of young breast cancer survivors, but also reinforce that some of our patients experience work difficulties. Currently there have been few evidence-based interventions that have successfully targeted improved employment outcomes following cancer. Further research is warranted to better understand long-term work trajectories in more diverse populations of young patients as well as work ability, productivity and stress among those who remain employed after cancer. Appropriate intervention focused on those struggling to participate in the labor force after cancer remains a significant, unmet need [33].

Informed consent:

Informed consent was obtained from all individual participants included in the study.

Acknowledgements:

Thank you to the young women with breast cancer who participated in our study.

Funding: Dr. Rosenberg is supported by grant number K01HS023680 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The funding agreement ensured the authors’ independence in designing the study, interpreting the data, writing, and publishing the report.

Dr. Partridge is supported by grants for efforts focused on young women with breast cancer from Susan G. Komen (SAC1000008), Breast Cancer Research Foundation (BCRF17-121), and U.S. Centers for Disease Control (CDC-U58DP005385).

Dr. Vaz-Luis is supported by grants from Susan G. Komen (CCR17483507), ARC, and Odyssea.

Footnotes

Publisher's Disclaimer: This Author Accepted Manuscript is a PDF file of an unedited peer-reviewed manuscript that has been accepted for publication but has not been copyedited or corrected. The official version of record that is published in the journal is kept up to date and so may therefore differ from this version.

Conflict of interest:

Dr. Partridge: Royalties from UpToDate.

Dr. Vaz-Luiz: Novartis, Astra-Zeneca, Ipsen (paid speaker).

No other authors report relevant disclosures.

Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of these institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

REFERENCES

  • [1].de Moor JS, Mariotto AB, Parry C, Alfano CM, Padgett L, Kent EE, Forsythe L, Scoppa S, Hachey M, Rowland JH (2013) Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev 22(4): 561–70 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1): 7–34 [DOI] [PubMed] [Google Scholar]
  • [3].“6 Employment, Insurance, and Economic Issues” From Cancer Patient to Cancer Survivor: Lost in Transition, The National Academies Press, Washington, DC, 2005. [Google Scholar]
  • [4].Amir Z, Brocky J (2009) Cancer survivorship and employment: epidemiology. Occup Med (Lond) 59(6): 373–7 [DOI] [PubMed] [Google Scholar]
  • [5].Blinder V, Eberle C, Patil S, Gany FM, Bradley CJ (2017) Women With Breast Cancer Who Work For Accommodating Employers More Likely To Retain Jobs After Treatment. Health Aff (Millwood) 36(2): 274–281 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Jagsi R, Hawley ST, Abrahamse P, Li Y, Janz NK, Griggs JJ, Bradley C, Graff JJ, Hamilton A, Katz SJ (2014) Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer. Cancer 120(12): 1854–62 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Jagsi R, Abrahamse PH, Lee KL, Wallner LP, Janz NK, Hamilton AS, Ward KC, Morrow M, Kurian AW, Friese CR, Hawley ST, Katz SJ (2017) Treatment decisions and employment of breast cancer patients: Results of a population-based survey. Cancer 123(24): 4791–4799 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Bouknight RR, Bradley CJ, Luo Z (2006) Correlates of return to work for breast cancer survivors. J Clin Oncol 24(3): 345–53 [DOI] [PubMed] [Google Scholar]
  • [9].Wang L, Hong BY, Kennedy SA, Chang Y, Hong CJ, Craigie S, Kwon HY, Romerosa B, Couban RJ, Reid S, Khan JS, McGillion M, Blinder V, Busse JW (2018) Predictors of Unemployment After Breast Cancer Surgery: A Systematic Review and Meta-Analysis of Observational Studies. J Clin Oncol 36(18): 1868–1879 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Noeres D, Park-Simon TW, Grabow J, Sperlich S, Koch-Giesselmann H, Jaunzeme J, Geyer S (2013) Return to work after treatment for primary breast cancer over a 6-year period: results from a prospective study comparing patients with the general population. Support Care Cancer 21(7): 1901–9 [DOI] [PubMed] [Google Scholar]
  • [11].de Boer AG, Taskila T, Ojajarvi A, van Dijk FJ, Verbeek JH (2009) Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA 301(7): 753–62 [DOI] [PubMed] [Google Scholar]
  • [12].Stone DS, Ganz PA, Pavlish C, Robbins WA (2017) Young adult cancer survivors and work: a systematic review. J Cancer Surviv [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Bradley CJ, Neumark D, Luo Z, Bednarek HL (2007) Employment-contingent health insurance, illness, and labor supply of women: evidence from married women with breast cancer. Health Econ 16(7): 719–37 [DOI] [PubMed] [Google Scholar]
  • [14].Lilliehorn S, Hamberg K, Kero A, Salander P (2013) Meaning of work and the returning process after breast cancer: a longitudinal study of 56 women. Scand J Caring Sci 27(2): 267–74 [DOI] [PubMed] [Google Scholar]
  • [15].Peugniez C, Fantoni S, Leroyer A, Skrzypczak J, Duprey M, Bonneterre J (2011) Return to work after treatment for breast cancer: single center experience in a cohort of 273 patients. Bull Cancer 98(7): E69–79 [DOI] [PubMed] [Google Scholar]
  • [16].Narod SA (2012) Breast cancer in young women. Nat Rev Clin Oncol 9(8): 460–70 [DOI] [PubMed] [Google Scholar]
  • [17].SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations), http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, 2012., 2012.
  • [18].Howard-Anderson J, Ganz PA, Bower JE, Stanton AL (2012) Quality of Life, Fertility Concerns, and Behavioral Health Outcomes in Younger Breast Cancer Survivors: A Systematic Review. J Natl Cancer Inst [DOI] [PubMed] [Google Scholar]
  • [19].Guy GP Jr., Yabroff KR, Ekwueme DU, Smith AW, Dowling EC, Rechis R, Nutt S, Richardson LC (2014) Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults. Health Aff (Millwood) 33(6): 1024–31 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [20].The Office for National Statistics UK (2010) SOC2010 volume 3: the National Statistics Socio-economic classification (NS-SEC rebased on the SOC2010) User Manual. [Google Scholar]
  • [21].Sonnega A, Faul JD, Ofstedal MB, Langa KM, Phillips JW, Weir DR (2014) Cohort Profile: the Health and Retirement Study (HRS). Int J Epidemiol 43(2): 576–85 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Gierisch JM, Earp JA, Brewer NT, Rimer BK (2010) Longitudinal predictors of nonadherence to maintenance of mammography. Cancer Epidemiol Biomarkers Prev 19(4): 1103–11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].van Muijen P, Weevers NL, Snels IA, Duijts SF, Bruinvels DJ, Schellart AJ, van der Beek AJ (2013) Predictors of return to work and employment in cancer survivors: a systematic review. Eur J Cancer Care (Engl) 22(2): 144–60 [DOI] [PubMed] [Google Scholar]
  • [24].Lauzier S, Maunsell E, Drolet M, Coyle D, Hebert-Croteau N, Brisson J, Masse B, Abdous B, Robidoux A, Robert J (2008) Wage losses in the year after breast cancer: extent and determinants among Canadian women. J Natl Cancer Inst 100(5): 321–32 [DOI] [PubMed] [Google Scholar]
  • [25].Carlsen K, Ewertz M, Dalton SO, Badsberg JH, Osler M (2014) Unemployment among breast cancer survivors. Scand J Public Health 42(3): 319–28 [DOI] [PubMed] [Google Scholar]
  • [26].Mujahid MS, Janz NK, Hawley ST, Griggs JJ, Hamilton AS, Graff J, Katz SJ (2011) Racial/ethnic differences in job loss for women with breast cancer. J Cancer Surviv 5(1): 102–11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Hedayati E, Johnsson A, Alinaghizadeh H, Schedin A, Nyman H, Albertsson M (2013) Cognitive, psychosocial, somatic and treatment factors predicting return to work after breast cancer treatment. Scand J Caring Sci 27(2): 380–7 [DOI] [PubMed] [Google Scholar]
  • [28].Paraponaris A, Teyssier LS, Ventelou B (2010) Job tenure and self-reported workplace discrimination for cancer survivors 2 years after diagnosis: does employment legislation matter? Health Policy 98(2–3): 144–55 [DOI] [PubMed] [Google Scholar]
  • [29].Barnes AJ, Robert N, Bradley CJ (2014) Job attributes, job satisfaction and the return to health after breast cancer diagnosis and treatment. Psychooncology 23(2): 158–64 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Lindbohm ML, Kuosma E, Taskila T, Hietanen P, Carlsen K, Gudbergsson S, Gunnarsdottir H (2014) Early retirement and non-employment after breast cancer. Psychooncology 23(6): 634–41 [DOI] [PubMed] [Google Scholar]
  • [31].Hassett MJ, O’Malley AJ, Keating NL (2009) Factors influencing changes in employment among women with newly diagnosed breast cancer. Cancer 115(12): 2775–82 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Drolet M, Maunsell E, Mondor M, Brisson C, Brisson J, Masse B, Deschenes L (2005) Work absence after breast cancer diagnosis: a population-based study. CMAJ 173(7): 765–71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Hoving JL, Broekhuizen ML, Frings-Dresen MH (2009) Return to work of breast cancer survivors: a systematic review of intervention studies. BMC Cancer 9 117. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES